End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,300 KRW | 0.00% | -0.10% | -12.49% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
Sales 2022 | 793B 576M 787M | Sales 2023 | 804B 585M 798M | Capitalization | 181B 131M 179M |
---|---|---|---|---|---|
Net income 2022 | -74.56B -54.2M -73.96M | Net income 2023 | -16.25B -11.81M -16.12M | EV / Sales 2022 | 0.44 x |
Net Debt 2022 | 109B 79.4M 108M | Net Debt 2023 | 155B 113M 154M | EV / Sales 2023 | 0.42 x |
P/E ratio 2022 |
-3.17
x | P/E ratio 2023 |
-11.1
x | Employees | 39 |
Yield 2022 |
0.32% | Yield 2023 |
0.42% | Free-Float | 13.57% |
1 week | -0.10% | ||
Current month | -4.98% | ||
1 month | -7.21% | ||
3 months | -5.94% | ||
6 months | +3.52% | ||
Current year | -12.49% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Cheol Han
CEO | Chief Executive Officer | 48 | - |
Bong-Hui Moon
BRD | Director/Board Member | 72 | - |
Seung-Soo Han
PRN | Corporate Officer/Principal | 76 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Seung-Soo Han
PRN | Corporate Officer/Principal | 76 | - |
Sang-Cheol Han
CEO | Chief Executive Officer | 48 | - |
Bong-Hui Moon
BRD | Director/Board Member | 72 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 10,300 | 0.00% | 6,931 |
24-04-25 | 10,300 | -3.56% | 19,140 |
24-04-24 | 10,680 | +2.40% | 22,418 |
24-04-23 | 10,430 | +1.66% | 12,074 |
24-04-22 | 10,260 | -0.48% | 16,852 |
End-of-day quote Korea S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-12.49% | 115M | |
+20.81% | 43.34B | |
+20.44% | 21.96B | |
+13.08% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A002620 Stock